RYTMHealthcareMid-Cap
RHYTHM PHARMACEUTICALS, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for RHYTHM PHARMACEUTICALS, INC. (RYTM), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are RYTM insiders buying or selling?
RHYTHM PHARMACEUTICALS, INC. insiders reported 1 open-market buys ($201.7K) and 168 sells ($149.6M) across 169 Form 4 filings — a net selling position of $149.4M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 24, 2026)
Total Form 4 filings
169
SEC EDGAR
Insider filers
18
Insider buys (1)
$201.7K
Insider sells (168)
$149.6M
Insider sentiment
Net sellingNet insider flow of $149.4M in net selling.
Recent RYTM insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 24, 2026 | Lynn A. Tetrault | Director | Sale | 37.0K | $100.32 | $3.7M |
| May 19, 2026 | Christopher Paul German | Corporate Controller & CAO | Sale | 4.6K | $92.21 | $428.1K |
| Mar 6, 2026 | Christopher Paul German | Corporate Controller & CAO | Sale | 5.6K | $89.56 | $502.8K |
| Feb 20, 2026 | Hunter C Smith | Chief Financial Officer | Sale | 8.0K | $101.31 | $805.8K |
| Feb 13, 2026 | Hunter C Smith | Chief Financial Officer | Sale | 7.1K | $100.21 | $708.6K |
| Feb 6, 2026 | Hunter C Smith | Chief Financial Officer | Sale | 6.6K | $106.03 | $702.7K |
| Dec 15, 2025 | Pamela J. Cramer | Chief Human Resources Officer | Sale | 3.4K | $111.00 | $371.9K |
| Nov 24, 2025 | Pamela J. Cramer | Chief Human Resources Officer | Sale | 3.4K | $105.00 | $351.8K |
| Nov 12, 2025 | Pamela J. Cramer | Chief Human Resources Officer | Sale | 22.9K | $99.00 | $2.3M |
| Nov 3, 2025 | Joseph Shulman | Chief Technical Officer | Sale | 9.7K | $115.24 | $1.1M |
| Oct 30, 2025 | Joseph Shulman | Chief Technical Officer | Sale | 2.8K | $115.01 | $323.8K |
| Oct 20, 2025 | Joseph Shulman | Chief Technical Officer | Sale | 14.4K | $112.03 | $1.6M |
| Sep 4, 2025 | Joseph Shulman | Chief Technical Officer | Sale | 16.8K | $105.30 | $1.8M |
| Aug 26, 2025 | Joseph Shulman | Chief Technical Officer | Sale | 4.2K | $100.07 | $419.1K |
| Aug 14, 2025 | Hunter C Smith | Chief Financial Officer | Sale | 28.1K | $96.29 | $2.7M |
| Aug 14, 2025 | Christopher Paul German | Corporate Controller & CAO | Sale | 1.5K | $95.00 | $142.5K |
| Aug 13, 2025 | Joseph Shulman | Chief Technical Officer | Sale | 4.0K | $90.08 | $358.9K |
| Jul 29, 2025 | Pamela J. Cramer | Chief Human Resources Officer | Sale | 1.5K | $85.93 | $130.6K |
| Jul 11, 2025 | Hunter C Smith | Chief Financial Officer | Sale | 42.1K | $80.48 | $3.4M |
| Jul 11, 2025 | Joseph Shulman | Chief Technical Officer | Sale | 8.0K | $77.78 | $619.9K |
| Jul 11, 2025 | Christopher Paul German | Corporate Controller & CAO | Sale | 3.8K | $80.75 | $308.2K |
| Jul 11, 2025 | Pamela J. Cramer | Chief Human Resources Officer | Sale | 15.6K | $77.13 | $1.2M |
| Jul 3, 2025 | Alastair Garfield | Chief Scientific Officer | Sale | 1.3K | $64.81 | $85.5K |
| Jun 12, 2025 | Christopher Paul German | Corporate Controller & CAO | Sale | 2.1K | $67.19 | $139.0K |
| Jun 10, 2025 | Pamela J. Cramer | Chief Human Resources Officer | Sale | 7.0K | $68.05 | $478.4K |
Showing the 25 most recent of 169 Form 4 filings for RHYTHM PHARMACEUTICALS, INC..
Most active RYTM insiders
- Joseph Shulman26 filings
- Pamela J. Cramer24 filings
- Todd Foley22 filings
- Hunter C Smith20 filings
- Jennifer Kayden Lee19 filings
Ask anything about RYTM insider activity
Use Trabud's AI agent to query RHYTHM PHARMACEUTICALS, INC.'s Form 4 history in plain English — "Show me RYTM CEO purchases this year" or compare it against any other ticker.
Open the AI agentRYTM insider trading FAQ
Are RHYTHM PHARMACEUTICALS, INC. insiders buying or selling?
Across 169 SEC Form 4 filings, RHYTHM PHARMACEUTICALS, INC. (RYTM) insiders reported 1 open-market purchases totaling $201.7K and 168 sales totaling $149.6M. That is a net selling position of $149.4M.
How many insiders trade RYTM stock?
18 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for RHYTHM PHARMACEUTICALS, INC.. The most recent filing was accepted on Jun 24, 2026.
Where does Trabud get RYTM insider trading data?
All RYTM insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.